To meet sales goals amid a stock price slide and criticism of its Model S, electric-car maker Tesla is offering incentives for current customers to help recruit new ones.
China, the largest economy in Asia and the second-largest in the world, is also the world's largest consumer of crude oil.
The stock price of Canadian drugmaker Valeant Pharmaceuticals dropped sharply Wednesday, triggering a trading halt, after a report questioned its data and practices.
Canada has for years grown its mining empire in Latin America, largely ignoring complaints of violence, kidnapping, extortion and environmental damage.
The International Energy Agency said Wednesday that growth in carbon emissions from fuel and electricity could plateau or decline within 15 years.
“I’m not willing to trade away safety for convenience,” said the city's mayor, who threatened to veto the measure.
Walmart has removed all "Made in the U.S.A." logos from its website after an investigation revealed that not all the labeled products fit that description.
The German state of Lower Saxony, which filed the complaint, is reportedly a minority shareholder and its governor is on the automaker’s supervisory board.
Starbucks said it will appeal the ruling, while Fiat Chrysler Automobiles denied receiving any tax benefit.
After Chinese investors suffered losses on record-high priced Bordeaux a few years ago, demand for 'En Primeur' futures contracts has withered on the vine.
Goldman Sachs is the sixth foreign company to exit the Indian mutual funds market since 2013.
About 2.7 million vehicles in North America, 1.2 million in Europe and 600,000 in Japan were recalled over a glitch that could potentially lead to a fire.
Transport authorities in Bangalore are considering local rules that will regulate the dynamic pricing followed by ride-hailing service providers such as Uber and local competitor Ola Cabs, according to a report.
The Swiss lender announced Wednesday it would raise $6.3 billion in fresh capital, after reporting a sharper-than-expected drop in third-quarter profits.
Consolidated revenue rose over 11 percent in the second quarter on higher demand for its research services unit, the company said, in a statement Tuesday.
Layoffs, expected to be announced Wednesday, reportedly will affect as many as 350 employees, or 4.3 percent of an 8,000-member payroll.
Justin Trudeau, Canada's prime minister-designate, has far different environmental policy ideas than Stephen Harper, which could mean trouble for the pipeline plan.
CEO Marissa Mayer's company fell short on revenue and earnings per share, but announced a search advertising partnership with its larger rival.
The French bank will pay $787 million to settle charges that it did business with Sudan, Iran and other sanctioned regimes between 2003 and 2008.
Biotech companies like Satori, where Mark Findeis headed up research, reveal a nuanced portrait of innovation.
The publication withdrew its recommendation for the vehicle, causing the California automaker's stock price to fall.
"If we are above $60 by the end of 2016, I will be a little bit surprised."
With increased competition and fewer new subscribers, the world's largest telecom, China Mobile Ltd., posted lower than estimated profits.
The news of the job cuts comes after days of speculation over the company's future plans in the U.K.
In India, where Apple's latest phone sells for nearly $1,000 buyers are willing to risk loss of warranty and other benefits for discounted prices, according to the Economic Times.
As retailers hold hiring to last year's levels, Amazon aims to hire 100,000 employees this holiday season.
The National Credit Union Agency has sued several companies over securities sold to credit unions that failed during the financial crisis.
CEO Oscar Munoz is on medical leave, following a heart attack he suffered last week.
Big Blue, which reported lower-than-expected quarterly sales Monday, could face "a prolonged period of underperformance" as it moves to the cloud.
Sprout Pharmaceuticals' agreement with regulators will force it to focus on educating doctors and pharmacists, rather than placing ads about the drug.